| Factor Information | |
|---|---|
| Data ID | 1486 |
| Factor | serum lactate |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | infant with CHD |
| p Value | <0.001 |
| Conclusion | Patients born at a hospital that did not stock PGE had significantly greater serum lactate on admission to our institution. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 533 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS/TGA/CoA/IAA/PA/TOF/TA/HAA/SV |
| Reference | |
|---|---|
| PMID | 26499357 |
| Year | 2016 |
| Title | Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | infant | |
| Source | data | |
| Region | Houston, USA | |
| Method | Student’s t test and Wilcoxon rank-sum test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | local PGE group and non-local group(Treatment) | non-local, no PGE group(Control) |
| Number | 265(Local PGE group) and 66(non-local PGE group) | 40 |
| Age | 0-2 days | 0-2 days |
| Gender (Male: Female) | 156:109(Local PGE group) and 28:38(non-local PGE group) | 27:13 |
| Marker Level | 2.9±2.3mg/l(local PGE group),3.1±2.7mg/l(non-local group) | 4.1±4.4mg/l |
